Regenstrief Institute Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2009
NCT00842608
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Regenstrief Institute, Center for Aging Research | Regenstrief Institute, Inc.